Asahi Songwon is a specialty chemicals company producing dyes, pigments, and APIs, with core segments in Blue Pigments (15.6% EBITDA margin in Q4 FY26), AZO Pigments (targeting 13% EBITDA margin at 85% utilization), and APIs (aiming for 15-16% EBITDA via CEP certification and backward integration). Growth will accelerate from AZO utilization reaching 75-85% (triggering Rs. 10-15 crore CAPEX expansion), CEP certification for Pregabalin (unlocking European markets by Q3/Q4 FY27), and API Chhatral plant utilization improving to 60-85% over 12-18 months. The business is on track to deliver Rs. 1,000 crore revenue within 3 years, with AZO exports doubling to 50% of sales and Blue Pigments maintaining operational efficiencies. Key execution risks include timely CEP approval for APIs and scaling AZO utilization to justify CAPEX.
companyname: Asahi Songwon Colors Limited ticker: ASAHISONG sector: Specialty Chemicals & Pharmaceuticals Asahi Songwon Colors Limited manufactures pigments and active pharmaceutical ingredients (APIs). It has been in business for over three decades and operates four manufacturing facilities in Gujarat at Padra (Phthalocyanine blue), Odhav (APIs), Dahej (Azo pigments), and Chhatral (API intermediates). The company sells to over 100 customers across 18 countries including the USA, Europe, Japan,...
Read the full report →capex, margin expansion, regulatory approval, debt reduction
AZO utilization expected to reach 75-85% in next 3-4 quarters, triggering Rs. 10-15 crore CAPEX expansion
Guidance upgradedGet valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Asahi Songwon Colors Limited and 4,900+ companies.
5-day free pass. No card required.